| Name | Eligibility | More information |
|---|---|---|
| Environmental risk factors for the antisynthetase syndrome |
Adults and children with myositis, with or without antisynthetase autoantibodies |
More details; Nastaran Bayat, MD 301-451-2348; NCT01276470 |
| MYOPROSP (Prospective cohort study in myositis) |
Adults with form of IIM, including AS syndrome, overlap, suspected myositis, CTD with MSA/MAA |
More details; Paul New +442755993; NCT02468895 |
| Studies in the natural history and pathogensis of childhood-onset idiopathic inflammatory myopathies |
Adults and children with DM, PM, and sIBM, and related conditions |
More details; Lisa Rider 301-451-6272; NCT00017914 |
| Study and Treatment of Inflammatory Muscle Diseases | Adults and children, aged 16 or higher, with IIM (suspected or confirmed) |
More details; Eileen Lange 301-432-8434; NCT00001265 |
| Evaluation of Clinical responsiveness of DM using Cutaneous DM Diseases Area and Severity Index (CDASI) | Adults with DM | More details; Victoria Werth 215-898-0168; NCT02945345 |
| IBM disease registry at Yale | IBM patients are encouraged to join the study and obtain your personal measure on the IBM Personalized Index Calculator | https://publichealth.yale.edu/ibmregistry/ |